Physician profile
Devon Lewis
NPI 1114507357
$1,845.19
in general payments reported to CMS, 2019-2025
30 companies · $689 in 2025
The $689 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.37 · 2022: $288 · 2023: $451 · 2024: $405 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,460 · Education: $71.49 · Entertainment: $13.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.77 |
| Education | $71.49 |
| Entertainment | $13.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $303.82 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $188.54 | 2025 | Austedo Xr, Uzedy |
| Vanda Pharmaceuticals INC. | $163.54 | 2025 | Fanapt |
| Philips North America LLC | $124.82 | 2023-2024 | (5044) Mcot, (Ck7) Extended Holter |
| Lilly USA, LLC | $113.11 | 2022-2024 | Mounjaro, Trulicity |
| Amgen INC. | $96.57 | 2022-2023 | Repatha, Otezla |
| Inspire Medical Systems, INC. | $94.63 | 2024 | Inspire |
| Almatica Pharma LLC | $68.96 | 2025 | Loreev Xr |
| Genzyme Corporation | $67.85 | 2024 | |
| Hologic Sales and Service, LLC | $65.08 | 2024 | Aptima |
| Alkermes, INC. | $60.24 | 2025 | Aristada, Lybalvi |
| Lundbeck LLC | $51.65 | 2025 | Rexulti |
| Novo Nordisk INC | $50.90 | 2021-2023 | Rybelsus, Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.80 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $38.96 | 2025 | Trintellix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $31.41 | 2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $27.61 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $24.49 | 2025 | Abilify Maintena |
| Amarin Pharma, INC. | $24.15 | 2023 | |
| Janssen Pharmaceuticals, INC | $23.44 | 2025 | Spravato |
| Neurocrine Biosciences, INC. | $23.03 | 2025 | |
| Pfizer INC. | $19.93 | 2024 | |
| Glaxosmithkline, LLC. | $19.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.50 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.35 | 2022 | |
| Eisai INC. | $18.33 | 2022 | |
| Itamar Medical INC | $16.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.76 | 2023 | |
| Phadia US INC. | $15.75 | 2024 | Immunocap |
| Optos, INC. | $13.10 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.